Research Article
Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study
Table 1
Description characters of the patients and controls. Data is shown as mean ± standard deviation (SD).
| | Characters | Number of patients (%) | Number of controls (%) | value |
| | Sample size | 160 | 160 | | | Mean age ± SD (range) (years) | 54.13 ± 7.78 (37–74) | 54.03 ± 7.94 (38–74) | 0.826 | | BMI mean ± SD (kg/m2) | 24.71 ± 2.76 | 24.88 ± 2.76 | 0.948 | | Family history of cancer | | | 0.136 | | Yes | 24 (15%) | 8 (5%) | | | No | 136 (85%) | 152 (95%) | | | Menopausal status | | | 0.651 | | Premenopausal | 88 (55%) | 96 (60%) | | | Postmenopausal | 72 (45%) | 64 (40%) | | | History of pregnancy | | | 0.556 | | Yes | 152 (95%) | 148 (92.5%) | | | No | 8 (5%) | 12 (7.5%) | | | Uterine bleeding | | | | | Yes | 120 (75%) | | | | No | 40 (25%) | | | | FIGO stage | | | | | I | 44 (27.5%) | | | | II | 44 (27.5%) | | | | III | 32 (20%) | | | | IV | 40 (25%) | | | | Histology | | | | | Adenocarcinoma | 160 (100%) | | | | Nonadenocarcinoma | 0 (0%) | | |
|
|
